伊玛提克斯
IMTX
6.73
-0.41
-5.74%
伊玛提克斯
US · IMTX
#3173 按市值排名
上市于 2018
6.73
-0.41
-5.74%
实时 - 追踪5344个代码 - 心跳于442秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期(2026/Q3)披露持股的机构数量减少了2家。
- 机构持股总比例下降了1.6个百分点。
机构持股
- 机构持股比例
- 85.37% -1.62pp
- 机构数量
- 93 -2
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Hedge Fund34.25%
VC/PE Fund21.80%
Mutual Fund21.57%
Public Company6.76%
Individual/Insider3.45%
Government Pension Fund0.51%
Private Company0.46%
Other11.19%
主要股东 截至 2026-06-30
T. Rowe Price Group, Inc.
16.66% · 22.78M 股
dievini Hopp BioTech holding GmbH & Co. KG
10.90% · 14.90M 股
RTW Investments, LP
9.47% · 12.95M 股
Perceptive Advisors LLC
8.19% · 11.20M 股
Montanova Capital, LLC
8.19% · 11.19M 股
Baker Bros. Advisors LP
6.96% · 9.51M 股
Jefferies Financial Group Inc.
4.76% · 6.51M 股
Vestal Point Capital, LP
4.52% · 6.18M 股
Sofinnova Investments, Inc.
2.68% · 3.67M 股
Morgan Stanley
1.59% · 2.17M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪40份申报 · 12次买入 · 0次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Mathias Hothum | Non-Executive Director | 0.24% |
| Harpreet Singh | CEO, MD, Member of Management Board & Executive Director | 0.16% |
| Michael Atieh | Independent Non-Executive Director | 0.10% |
| Paul Carter | Independent Non-Executive Director | 0.10% |
| Heather Mason | Independent Vice Chair of the Board of Directors | 0.10% |
| Eliot Forster | Independent Non-Executive Director | 0.10% |
| Adam Stone | Independent Non-Executive Director | 0.10% |
| Peter Chambré | Non-Executive Chairperson | 0.08% |
| Carsten Reinhardt | Chief Development Officer | 0.03% |
| Alise Reicin | Director | 0.02% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-08-25 | Perceptive Advisors LLC | -- | Private Acquisition | +863,060 | $8.69 |
| 2026-08-13 | James Pepin | General Counsel | Other Derivative Acquisition | +43,800 | -- |
| 2026-08-13 | James Pepin | General Counsel | Other Derivative Acquisition | +181,200 | $9.44 |
| 2026-06-15 | Michael Atieh | Independent Non-Executive Director | Other Derivative Acquisition | +48,000 | $9.09 |
| 2026-06-15 | Peter Chambré | Non-Executive Chairperson | Other Derivative Acquisition | +48,000 | $9.09 |
| 2026-06-15 | Heather Mason | Independent Vice Chair of the Board of Directors | Other Derivative Acquisition | +48,000 | $9.09 |
| 2026-06-15 | Perceptive Advisors LLC | -- | Other Derivative Acquisition | +48,000 | $9.09 |
| 2026-06-15 | Eliot Forster | Independent Non-Executive Director | Other Derivative Acquisition | +48,000 | $9.09 |
| 2026-06-15 | Paul Carter | Independent Non-Executive Director | Other Derivative Acquisition | +48,000 | $9.09 |
| 2026-06-15 | Mathias Hothum | Non-Executive Director | Other Derivative Acquisition | +48,000 | $9.09 |
| 2026-06-15 | Alise Reicin | Director | Other Derivative Acquisition | +48,000 | $9.09 |
| 2026-06-15 | Adam Stone | Independent Non-Executive Director | Other Derivative Acquisition | +48,000 | $9.09 |
| 2026-03-17 | Michael Atieh | Independent Non-Executive Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Peter Chambré | Non-Executive Chairperson | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Heather Mason | Independent Vice Chair of the Board of Directors | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Perceptive Advisors LLC | -- | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Harpreet Singh | CEO, MD, Member of Management Board & Executive Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Carsten Reinhardt | Chief Development Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Eliot Forster | Independent Non-Executive Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Paul Carter | Independent Non-Executive Director | Initial Statement of Beneficial | 0 | -- |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
伊玛提克斯 讨论区 0 条评论